| scholarly article | Q13442814 |
| P2093 | author name string | A Bell | |
| J P Dalton | |||
| S G Machado | |||
| C S Gavigan | |||
| P2860 | cites work | Hemoglobin metabolism in the malaria parasite Plasmodium falciparum | Q27973732 |
| Synergistic drug combinations in AIDS therapy. Dipyridamole/3'-azido-3'-deoxythymidine in particular and principles of analysis in general | Q28328662 | ||
| Hemoglobin degradation in the malaria parasite Plasmodium falciparum: an ordered process in a unique organelle | Q28972254 | ||
| Identification and characterization of falcilysin, a metallopeptidase involved in hemoglobin catabolism within the malaria parasite Plasmodium falciparum | Q30042132 | ||
| Identification of potent inhibitors of Plasmodium falciparum plasmepsin II from an encoded statine combinatorial library | Q31942481 | ||
| Antimalarial synergy of cysteine and aspartic protease inhibitors | Q33696222 | ||
| Order and specificity of the Plasmodium falciparum hemoglobin degradation pathway | Q34139669 | ||
| A malarial cysteine proteinase is necessary for hemoglobin degradation by Plasmodium falciparum | Q35592776 | ||
| Antimalarial drug resistance: the pace quickens | Q35665093 | ||
| Strategies for the prevention of antimalarial drug resistance: rationale for combination chemotherapy for malaria | Q35846117 | ||
| Structure-based inhibitor design by using protein models for the development of antiparasitic agents | Q36252297 | ||
| Statistical analysis of drug-drug and site-site interactions with isobolograms | Q38699327 | ||
| Disease problems in the Third World | Q38776269 | ||
| Malaria, the submerged disease | Q39322893 | ||
| Synergy, additivism and antagonism in immunosuppression. A critical review | Q39622779 | ||
| Malaria vaccines: multiple targets | Q40695819 | ||
| Antagonists of Nucleic Acid Derivatives Viii. Synergism in Combinations of Biochemically Related Antimetabolites | Q40910881 | ||
| Antimalarial effects in mice of orally administered peptidyl cysteine protease inhibitors | Q41669282 | ||
| The efficacy of antifolate antimalarial combinations in Africa: a predictive model based on pharmacodynamic and pharmacokinetic analyses | Q41913682 | ||
| Aminopeptidases from Plasmodium falciparum, Plasmodium chabaudi chabaudi and Plasmodium berghei | Q43023116 | ||
| The role of aminopeptidases in haemoglobin degradation in Plasmodium falciparum-infected erythrocytes | Q43733737 | ||
| A Method for Testing for Synergy with Any Number of Agents | Q44778227 | ||
| Generation of hemoglobin peptides in the acidic digestive vacuole of Plasmodium falciparum implicates peptide transport in amino acid production | Q48037131 | ||
| Lecture on the Antagonism between the Actions of Active Substances. | Q48582933 | ||
| Application of a new approach for the quantitation of drug synergism to the combination of cis-diamminedichloroplatinum and 1-beta-D-arabinofuranosylcytosine. | Q52473169 | ||
| Measurement of the Potencies of Drug Mixtures | Q52507424 | ||
| The expected effect of a combination of agents: the general solution. | Q52667906 | ||
| Localization and characterization of hemoglobin-degrading aspartic proteinases from the malarial parasite Plasmodium falciparum | Q68017340 | ||
| Plasmodium falciparum: differential sensitivity in vitro to E-64 (cysteine protease inhibitor) and Pepstatin A (aspartyl protease inhibitor) | Q68041234 | ||
| Toxicological studies on bestatin. I. Acute toxicity test in mice, rats and dogs | Q71207493 | ||
| A direct, general approach based on isobolograms for assessing the joint action of drugs in pre-clinical experiments | Q72544025 | ||
| The problem of synergism and antagonism of combined drugs | Q73248616 | ||
| Plasmodium chabaudi chabaudi and P. falciparum: inhibition of aminopeptidase and parasite growth by bestatin and nitrobestatin | Q77051404 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | statistics | Q12483 |
| antimalarial | Q521616 | ||
| P304 | page(s) | 3175-3181 | |
| P577 | publication date | 2001-11-01 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Analysis of antimalarial synergy between bestatin and endoprotease inhibitors using statistical response-surface modelling | |
| P478 | volume | 45 |
| Q27671783 | Bestatin-based chemical biology strategy reveals distinct roles for malaria M1- and M17-family aminopeptidases |
| Q36870833 | Chemical target validation studies of aminopeptidase in malaria parasites using alpha-aminoalkylphosphonate and phosphonopeptide inhibitors |
| Q39017667 | Overexpression of leucyl aminopeptidase in Plasmodium falciparum parasites. Target for the antimalarial activity of bestatin |
| Q27653672 | Structural basis for the inhibition of the essential Plasmodium falciparum M1 neutral aminopeptidase |
| Q36018855 | The aminopeptidase inhibitor CHR-2863 is an orally bioavailable inhibitor of murine malaria |
| Q47988678 | The antimalarial action of FK506 and rapamycin: evidence for a direct effect on FK506-binding protein PfFKBP35. |
Search more.